This retrospective study evaluates the long term efficacy of pars plana vitrectomy on the preservation of vision in complicated chronic uveitis, including endogenous intermediate uveitis and other entities. Combined vitrectomy-lensectomy was performed in 10 eyes with complicated cataracts, and 18 vitrectomies were done without lensectomies. The mean follow up was 45 months. Additional retinal surgery (for example, scleral buckling) was performed in five eyes. Visual acuity improved in 23 eyes (82.8%) following surgery, with 16 eyes (57%) achieving a vision better than 6/24. The main causes for vision less than 6/24 were persistent cystoid macular oedema (three eyes), macular puckers (one eye), retinal vascular obliterations (four eyes), optic atrophy (five eyes), and chorioretinal scars (seven eyes). Postoperative complications were cataract formation (seven eyes), cystoid macular oedema (one eye), and tractional retinal detachments (three eyes). The surgical intervention resulted in a remarkable reduction of the severity of inflammation or frequency of exacerbations, and allowed significant tapering (11 eyes) or withdrawal (11 eyes) of the topical steroids, or oral corticosteroids (10 cases). Pre-existent cystoid macular oedema resolved in three eyes. Pars plana vitrectomy, eventually combined with lensectomy, may visually rehabilitate eyes with chronic uveitis and media opacities, and may reduce the activity of disease postoperatively. (Br_J Ophthalmol 1994; 78: 549-554) are resistant to corticosteroids and develop active neovascularisation.2
disease postoperatively. (Br_J Ophthalmol 1994; 78: 549-554) are resistant to corticosteroids and develop active neovascularisation. 2 Traditional indications for a surgical intervention in chronic uveitis have been the presence of complicated cataracts and advanced posterior synechiae with secondary glaucoma. 3 The surgical removal of cataracts in uveitis via a limbal approach is complicated by operative difficulties caused by iris atrophy, pupillary sphincter sclerosis, posterior synechiae, haemorrhage from abnormal iris vasculature, and intense postoperative inflammation. 4 Based on the pioneering work of Diamond and Kaplan5 more recent approaches to the surgical treatment of chronic uveitis consisted of a pars plana approach not only to remove the cataract but also the inflammatory masses in the vitreous. Further indications for a pars plana access include vitreous haemorrhages and epiretinal membrane formation with subsequent tractional retinal detachment. Recent experimental data suggest that the persistence of the vitreous is associated with the reactivation of a secondary immune response.67 Consequently, the removal of the vitreous may have a favourable influence on the subsequent course of the basic inflammatory process.
The purpose of this retrospective study is to evaluate the results of a surgical pars plana vitrectomy in chronic uveitis complicated by dense vitreous flare and vitreous infiltration, or cataract formation, and to help in establishing indications for such an approach in these patients.
Materials and methods
The natural course of endogenous uveitis is variable, ranging from a selflimiting disease to an unrelenting, possibly blinding disease with multiple remissions and exacerbations.' Progression often results in cataract formation, synechiae, vitreous flare and haemorrhage, cystoid macular oedema, epiretinal membrane formation, secondary glaucoma, vasoproliferative changes, tractional and rhegmatogenous retinal detachment, hypotony, and eventually phthisis.
The therapeutic approach is dependent on the individual course of the disease. In Encircling scleral buckle procedures were performed in four eyes. In six eyes, sulphur hexafluoride (SF6) gas mixture was injected to achieve an internal tamponade. In two eyes, liquid silicone was used for retinal reattachment.
Endolaser photocoagulation was done in nine eyes with either vasoproliferative changes, minor disruptions of retinal vessels or small retinal tears. In seven eyes, cryocoagulations were applied when active neovascularisations of the vitreous base or retinal tears were visible.
Peripheral iridectomies were performed in three eyes. In two eyes, an inferior iridectomy was done because of silicone oil injection into aphakic eyes.
The postoperative management included topical and periocular corticosteroids. Antiinflammatory drugs, including systemic corticosteroids and chemotherapeutic regimens, were adjusted pre-and postoperatively to achieve quiescence.
Results
The ocular characteristics of the 28 eyes undergoing pars plana vitrectomy and lensectomy included cataract formation (13 eyes), ICCE (three eyes), or ECCE aphakia (one eye), retrolental cyclitic membranes (two eyes), vitreous haemorrhage (nine eyes), macular puckers (14 eyes), neovascularisation (17 eyes), tractional (nine eyes) or exudative (two eyes) retinal detachment, and retinal tears (one eye). The long term topical treatment with steroids had induced glaucoma in one case and cataract in another. Two patients had complications from systemic steroid medication including diabetes and arterial hypertension in one patient, and obesity and arterial hypertension in another.
Glaucoma was detected in four eyes preoperatively. These The degree of preoperative inflammatory activity was: no inflammatory activity in three cases, low inflammatory activity in 21 cases, and high inflammatory activity in two cases with chorioretinitis, and in two patients with Behcet's diseases. In 11 patients, the topical corticosteroid medication could be discontinued postoperatively, while it could be strongly tapered in another 11 cases. While quiescence was not achieved during the preoperative course in 17 cases without oral prednisolone, the systemic corticosteroid treatment could be withdrawn postoperatively in 10 cases. Since one patient with systemic lupus erythematosus has been in complete remission during the last 4 years, the systemic immunosuppression was discontinued. Systemic immunosuppressive chemotherapy was continued postoperatively in six cases with systemic immune disorders, namely Behcet's disease, VKH syndrome, and systemic vasculitis. Details of the preoperative and postoperative medical regimen are shown in Table 1 . The average of months the inflammation persisted was reduced from 9-9 months per year preoperatively (0-63 SEM) to 1-7 months per year postoperatively (0-49 SEM) for all patients (Student's t test, p<0-0001). Furthermore, the number of acute exacerbations of inflammation was reduced from a preoperative average of 3-17 per year (0-22 SEM) to an average of 0-82 exacerbations per year postoperatively (0-21 SEM; Student's t test, p<00001), as listed in Table 2 .
Cystoid macular oedema was present in six eyes pre-or intraoperatively, and the patients' clinical characteristics are listed in Table 3 . Cystoid macular oedema did not resolve postoperatively in three eyes resulting in visual acuities of 6/24, 6/36, and 6/60. Cystoid macular oedema resolved in three eyes within 12 to 15 months after surgery with a visual outcome of 6/7 5, 6/9, and 6/9. There were no significant differences between these two groups in terms of the underlying disease; all but one had endogenous uveitis, and chorioretinitis was present in one eye. The surgical procedures were similar in both groups. There was no significant influence ofthe duration and preoperative frequency ofthe inflammatory attacks, or of vitreous haze or The instantaneous postoperative beneficial effect on visual acuity is produced by surgical removal of media opacities obscuring the optical axis. The long term effect shown by this study may be caused by a possible therapeutic effect related to removing of vitreal debris and immunocompetent inflammatory cells, thus leading to a decreased incidence and severity of recurrences.47 Experimental results suggest that the persistence of the vitreous is associated with the reactivation of a secondary immune response. 7 There is an extensive controversy in the literature on the appropriate surgical technique in pars plana vitrectomy for complicated uveitis. The main subject ofthis controversy is whether or not an attempt should be made to remove as much vitreous as possible or whether the operation should be confined to a core vitrectomy. Recommendations in the older literature based on poor results when a complete vitrectomy was performed"'1 are not valid when the recent improvements in instrumentation for intravitreal surgery are considered. Cystoid macular oedema threatens visual function in all patients with chronic uveitis and may prevent functional recovery after otherwise successful vitreoretinal surgery.2' The prevalence of cystoid macular oedema in patients undergoing pars plana vitrectomy described previously ranged from 13%3' to 56%,5 and was 26% in our series. Confirming previous observations,30 pars plana vitrectomy had a favourable outcome on cystoid macular oedema in our series as the oedema resolved in three patients within 12-15 months after surgery. Although Pederson and coworkers32 suggested (based on histopathological studies) that cystoid macular oedema in uveitis may be caused by infiltrative shortening of the vitreous base and posterior hyaloid detachment, a coincidence of cystoid macular oedema and posterior hyaloid detachment could not be detected in our series. Even in the presence of cystoid macular oedema, visual acuity improved in our series (ranging from 6/60 to 6/12). Assessing macular function preoperatively is crucial.
According to Nussenblatt, 30 laser interferometry gives the most reliable results, while visual evoked responses are less accurate. However, none of these methods seems to be applicable to predicting the possible occurrence and duration of cystoid macular oedema after surgery.
In conclusion, pars plana vitrectomy is 
